Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy. - Wikidata - awgldk - TriplyDB

Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy.

Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy.

http://www.wikidata.org/entity/Q44748710

about

New insights into MicroRNAs involves in drug resistance in diffuse large B cell lymphoma Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment.Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland.Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component.Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic options.EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.[Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients.In Europe expression of EBNA2 is associated with poor survival in EBV-positive diffuse large B-cell lymphoma of the elderly.Clinical characteristics and treatment outcome in a Taiwanese population of patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.Outcomes among US patients with diffuse large B cell lymphoma are independent of tumor Epstein Barr virus positivity or immunosuppression.

P2860

Q26765273-A6C3F5DD-D8A9-4269-97EB-BA2A866F413D Q33583294-96BFCBF0-2CEF-48FE-B641-204A8BB858A0 Q35713686-B2B4B549-3296-4DB2-AA46-32A5C9A5FA28 Q35880791-DB27D8CF-8C16-467F-87BE-098A05737ABF Q35953524-43CA9717-2CED-43D1-A4AF-2CF27ADF2878 Q35987244-BF7C2C54-4234-4BEB-9E2A-F18CF62B295A Q36723872-23C927E3-E8CA-4354-AC1D-4BF1507EF638 Q37685724-386C4373-596C-4338-8DD2-07670E418998 Q38720593-AA3297CC-179E-4375-B040-F6260523A063 Q38812004-545AC7FE-E0A3-4939-A6D8-F1B289F9D023 Q40080582-DC2065FB-130B-4542-AE8C-BE85C5AD4DD4 Q40150053-6CDB25FB-31DD-46CB-A775-7E9DAAEF9668 Q40321829-1060BE2D-EA44-4C59-9B93-A77B59F9BF64 Q40733407-C9583C27-6664-41C7-8C21-C74AA35F35CC Q41300276-5D4D2D5D-EFC4-49CD-843F-0BD0A82854B8 Q41699036-896E528C-FB83-493B-9005-B827302CE710 Q42256332-0347F9BA-9FBE-419E-9670-A551D2204397 Q45324330-277C9136-0021-4268-AF18-06858745324C

P2860

Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy.

http://www.wikidata.org/entity/Q44748710

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Clinical outcome of elderly pa ...... tuximab and CHOP chemotherapy.

@en

Clinical outcome of elderly pa ...... tuximab and CHOP chemotherapy.

@nl

type

label

Clinical outcome of elderly pa ...... tuximab and CHOP chemotherapy.

@en

Clinical outcome of elderly pa ...... tuximab and CHOP chemotherapy.

@nl

prefLabel

Clinical outcome of elderly pa ...... tuximab and CHOP chemotherapy.

@en

Clinical outcome of elderly pa ...... tuximab and CHOP chemotherapy.

@nl

P1433

Q44748710-20263143-AA19-4C39-B038-BFE88E0935A3

P1476

Q44748710-AEED20FC-E357-47C8-AD15-E4E25861AD95

P2093

Q44748710-0F7551F4-5328-4504-962C-657FFDE94024

Q44748710-1E663F5B-C76B-42A6-9D26-8435AD18AC33

Q44748710-358E99CC-6546-4132-B4E4-5211437BB893

Q44748710-5EC109E6-80AB-47FB-BD83-EBFCA88DF973

Q44748710-5FA17BAC-6E8F-428D-8D78-0F1C945940A7

Q44748710-66D94DB8-F0F3-44CA-8010-94C677D10DD9

Q44748710-7273AACD-38C6-4AB3-B026-C74352BBB2CD

Q44748710-8ACD76AE-F6F3-499F-B3DA-C48B9D9C5091

Q44748710-B8518883-27E7-4DFD-BC5E-539CF0417F31

Q44748710-F64E407D-CBA0-4213-A71D-E0AAA873F297

P2860

Q44748710-04B01322-7E3D-4744-8308-C2274C4AFD68

Q44748710-063647EF-A948-48FB-8951-CB803EEE701F

Q44748710-08298715-3262-43BA-A3F9-89A72AF00674

Q44748710-367005AF-334F-4B9C-9101-AE5E4E26473D

Q44748710-3682E84B-67DD-434F-BD0C-CA62566DF3D7

Q44748710-373A9E37-7F68-4743-80C8-66771A988A03

Q44748710-43AA98FF-127C-47EB-AB67-2FE1319D1017

Q44748710-43BD56D2-9878-4615-BA0B-798BD0CB04DD

Q44748710-4E9278C8-7647-47D3-A8AA-3D217B2D2595

Q44748710-50A766F6-647F-4C0D-8070-A0F85A3410F6

P304

Q44748710-3164EC23-8A1F-4BB7-A94C-22C647916908

P31

Q44748710-CEFC73D2-FE61-462D-8F2A-196A50160772

P356

Q44748710-C4263354-3C96-4DAD-88E7-A986E656E6A3

P433

Q44748710-B00B5561-D1A6-43BA-9F04-7025F0E4545F

P478

Q44748710-97AB5A59-0909-42E1-8A18-D12C05875611

P577

Q44748710-4E55F677-CB59-41B9-94C8-755BA0E2598D

P698

Q44748710-9144D4E9-9037-46CA-8BB9-16F57B67A065

P921

Q44748710-A8BC5867-6D4A-45A7-996B-6430BA9136E0

Q44748710-ACBAD293-AE18-4EEC-A811-AEFFB75FE27E

P356

P1433

American Journal of Hematology

P1476

Clinical outcome of elderly pa ...... tuximab and CHOP chemotherapy.

@en

P2093

Deok-Hwan Yang

http://www.w3.org/2001/XMLSchema#string

Ho Sung Park

http://www.w3.org/2001/XMLSchema#string

Ho-Young Yhim

http://www.w3.org/2001/XMLSchema#string

Hyeoung-Joon Kim

http://www.w3.org/2001/XMLSchema#string

Jae-Sook Ahn

http://www.w3.org/2001/XMLSchema#string

Jae-Yong Kwak

http://www.w3.org/2001/XMLSchema#string

Je-Jung Lee

http://www.w3.org/2001/XMLSchema#string

Myung-Geun Shin

http://www.w3.org/2001/XMLSchema#string

Sung-Hoon Jung

http://www.w3.org/2001/XMLSchema#string

Yeo-Kyeoung Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab: mechanism of action

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.

Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly.

Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.

Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.

Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations.

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

P304

774-779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.23507

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23760676

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus